Cited by 218Gut microbiota and healthGastrointestinal motility and disordersOral microbiology and periodontitis research

The DOI matches its Crossref record; 269 of the 270 references it cites were found in a registry or an index.

The promise of the gut microbiome as part of individualized treatment strategies

Open access

Schupack, Daniel A., Mars, Ruben A. T., Voelker, Dayne H., Abeykoon, Jithma P., Kashyap, Purna C.·2022·Nature Reviews Gastroenterology & Hepatology

DOI 10.1038/s41575-021-00499-1PMC PMC8712374

Open this paper in CoChat — free account

Abstract

Variability in disease presentation, progression and treatment response has been a central challenge in medicine. Although variability in host factors and genetics are important, it has become evident that the gut microbiome, with its vast genetic and metabolic diversity, must be considered in moving towards individualized treatment. In this Review, we discuss six broad disease groups: infectious disease, cancer, metabolic disease, cardiovascular disease, autoimmune or inflammatory disease, and allergic and atopic diseases. We highlight current knowledge on the gut microbiome in disease pathogenesis and prognosis, efficacy, and treatment-related adverse events and its promise for stratifying existing treatments and as a source of novel therapies. The Review is not meant to be comprehensive for each disease state but rather highlights the potential implications of the microbiome as a tool to individualize treatment strategies in clinical practice. Although early, the outlook is optimistic but challenges need to be overcome before clinical implementation, including improved understanding of underlying mechanisms, longitudinal studies with multiple data layers reflecting gut microbiome and host response, standardized approaches to testing and reporting, and validation in larger cohorts. Given progress in the microbiome field with concurrent basic and clinical studies, the microbiome will likely become an integral part of clinical care within the next decade.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41575-021-00499-1

Cites

269 of 269 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 201–269 of 269

Probiotics supplementation for the obesity management; A systematic review of animal studies and clinical trials
Ejtahed, H., Angoorani, P., Soroush, A., Atlasi, R., Hasani‐Ranjbar, S., Mortazavian, A. M., & Larijani, B. A. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.10.039 · Cited by 158
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
Witjes, J. J., Smits, L. P., Pekmez, C. T., Prodan, A., Meijnikman, A. S., Troelstra, M., Bouter, K. E. C., Herrema, H., Levin, E., Holleboom, A. G., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1601 · Cited by 158
Gut microbiota-mediated drug interactions between lovastatin and antibiotics
Yoo, D.-H., Kim, I. S., Van Le, T. K., Jung, I.-H., Yoo, H. H., & Kim, D.-H. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058354 · Cited by 158
A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
Zhao, L., Chen, Y., Xia, F., Abudukerimu, B., Zhang, W., Guo, Y., Wang, N., & Lu, Y. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00233 · Cited by 155
The role of microbiome in rheumatoid arthritis treatment
Bodkhe, R., Balakrishnan, B., & Taneja, V. (2019) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x19844632 · Cited by 152
Mucosal Immunology of Food Allergy
Berin, M. C., & Sampson, H. A. (2013) · Current Biology · doi:10.1016/j.cub.2013.02.043 · Cited by 151
Clostridium ramosum regulates enterochromaffin cell development and serotonin release
Mandić, A. D., Woting, A., Jaenicke, T., Sander, A., Sabrowski, W., Rolle-Kampcyk, U., von Bergen, M., & Blaut, M. (2019) · Scientific Reports · doi:10.1038/s41598-018-38018-z · Cited by 150
Faecalibacterium prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats
Zhang, M., Qiu, X., Zhang, H., Yang, X., Hong, N., Yang, Y., Chen, H., & Yu, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109146 · Cited by 147
Induction and Amelioration of Methotrexate-Induced Gastrointestinal Toxicity are Related to Immune Response and Gut Microbiota
Zhou, B., Xia, X., Wang, P., Chen, S., Yu, C., Huang, R., Zhang, R., Wang, Y., Lu, L., Yuan, F., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.029 · Cited by 146
Histamine-secreting microbes are increased in the gut of adult asthma patients
Barcik, W., Pugin, B., Westermann, P., Perez, N. R., Ferstl, R., Wawrzyniak, M., Smolinska, S., Jutel, M., Hessel, E. M., Michalovich, D., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.049 · Cited by 142
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
Ianiro, G., Rossi, E., Thomas, A. M., Schinzari, G., Masucci, L., Quaranta, G., Settanni, C. R., Lopetuso, L. R., Armanini, F., Blanco‐Míguez, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18127-y · Cited by 139
Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis
García‐Lezana, T., Raurell, I., Bravo, M., Torres‐Arauz, M., Salcedo, M. T., Santiago, A., Schoenenberger, A., Manichanh, C., Genescà, J., Martell, M., et al. (2018) · Hepatology · doi:10.1002/hep.29646 · Cited by 136
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
Madsen, M. S. A., Holm, J. B., Pallejá, A., Wismann, P., Fabricius, K., Rigbolt, K. T. G., Mikkelsen, M., Sommer, M. O. A., Jelsing, J., Nielsen, H. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52103-x · Cited by 131
Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo
Liu, Y., Song, X., Zhou, H., Zhou, X., Xia, Y., Dong, X. Z., Zhong, W., Tang, S., Wang, L., Wen, S., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00530 · Cited by 129
Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection
Khanna, S., Montassier, E., Schmidt, B. A., Patel, R., Knights, D., Pardi, D. S., & Kashyap, P. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13750 · Cited by 127
Self-citation
Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil
Nakayama, H., Kinouchi, T., Kataoka, K., Akimoto, S., Matsuda, Y., & Ohnishi, Y. (1997) · Pharmacogenetics · doi:10.1097/00008571-199702000-00005 · Cited by 120
New Approaches to Microbiome-Based Therapies
Wong, A. C., & Levy, M. (2019) · mSystems · doi:10.1128/msystems.00122-19 · Cited by 117
Changes in faecal microbiota of infants with cow’s milk protein allergy – a Spanish prospective case–control 6‐month follow‐up study
Chagoyán, Ó. C. T., Vieites, J. M., Maldonado, J., Edwards, C. A., & Gil, Á. (2009) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2009.00961.x · Cited by 116
Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease
Fornelos, N., Franzosa, E. A., Bishai, J. D., Annand, J. W., Oka, A., Lloyd‐Price, J., Arthur, T. D., Garner, A., Ávila-Pacheco, J., Haiser, H. J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0655-7 · Cited by 112
Sorivudine and 5‐fluorouracil; a clinically significant drug‐drug interaction due to inhibition of dihydropyrimidine dehydrogenase
Diasio, R. B. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00050.x · Cited by 111
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease
Negroni, A., Costanzo, M., Vitali, R., Superti, F., Bertuccini, L., Tinari, A., Minelli, F., Nardo, G. D., Nuti, F., Pierdomenico, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21899 · Cited by 109
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
Scales, B. S., Dickson, R. P., & Huffnagle, G. B. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-106r · Cited by 109
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
Brandt, A., Hernández-Arriaga, A. M., Kehm, R., Sánchez, V., Jin, C. J., Nier, A., Baumann, A., Camarinha‐Silva, A., & Bergheim, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-43228-0 · Cited by 108
Management of type 2 diabetes: summary of updated NICE guidance
Home, P., Mant, J., Diaz, J., & Turner, C. (2008) · BMJ · doi:10.1136/bmj.39560.442095.ad · Cited by 108
Defined microbiota transplant restores Th17/RORγt + regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
Britton, G. J., Contijoch, E. J., Spindler, M. P., Aggarwala, V., Dogan, B., Bongers, G., Mateo, L. S., Baltus, A. E., Das, A., Gevers, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922189117 · Cited by 106
Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine
Zheng, H., Chen, M., Li, Y., Wang, Y., Lin, W., Liao, Z., Wang, M., Ma, F., Liao, Q., & Xie, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01703 · Cited by 106
The formation of ethanol in Escherichia coli
DAWES, E. A., & Foster, S. M. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90148-2 · Cited by 101
Gut Microbial Carbohydrate Metabolism Hinders Weight Loss in Overweight Adults Undergoing Lifestyle Intervention With a Volumetric Diet
Pedrogo, D. A. M., Jensen, M. D., Dyke, C. T. V., Murray, J. A., Woods, J. A., Chen, J., Kashyap, P., & Nehra, V. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.02.019 · Cited by 97
Self-citation
Type IV pili promote early biofilm formation byClostridium difficile
Maldarelli, G. A., Piepenbrink, K. H., Scott, A. J., Freiberg, J. A., Song, Y., Achermann, Y., Ernst, R. K., Shirtliff, M. E., Sundberg, E. J., Donnenberg, M. S., et al. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw061 · Cited by 97
The microbiome and development of allergic disease
Lynch, S. V., & Boushey, H. A. (2016) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0000000000000255 · Cited by 92
RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice
Fu, Z. D., Selwyn, F. P., Cui, J. Y., & Klaassen, C. D. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.077313 · Cited by 82
Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine
Kumar, M., Garand, M., & Khodor, S. A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02174-1 · Cited by 81
Individualized Responses of Gut Microbiota to Dietary Intervention Modeled in Humanized Mice
Smits, S. A., Marcobal, A. M., Higginbottom, S. K., Sonnenburg, J. L., & Kashyap, P. (2016) · mSystems · doi:10.1128/msystems.00098-16 · Cited by 78
Self-citation
Simplified Intestinal Microbiota to Study Microbe-Diet-Host Interactions in a Mouse Model
Kovatcheva‐Datchary, P., Shoaie, S., Lee, S., Wahlstrom, A. M., Nookaew, I., Hallén, A., Perkins, R., Nielsen, J., & Bäckhed, F. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.090 · Cited by 77
Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Lopez, J., & Grinspan, A. M. (2016) · PubMed Central · Cited by 75
Interplay Between the Host, the Human Microbiome, and Drug Metabolism
Nichols, R. G., Peters, J. M., & Patterson, A. D. (2019) · Human Genomics · doi:10.1186/s40246-019-0211-9 · Cited by 75
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn’s Disease
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D. Y., Bittinger, K. L., Bailey, A., Friedman, E. S., Hoffmann, C., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.011 · Cited by 75
Clostridium difficile Infection and Fecal Microbiota Transplant
Liubakka, A. M., & Vaughn, B. P. (2016) · AACN Advanced Critical Care · doi:10.4037/aacnacc2016703 · Cited by 73
Fecal microbiota transplantation for inflammatory bowel disease
Wen, H.-Z. (2016) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v24.i10.1545 · Cited by 69
A Probe-Enabled Approach for the Selective Isolation and Characterization of Functionally Active Subpopulations in the Gut Microbiome
Whidbey, C., Sadler, N., Nair, R., Volk, R. F., DeLeon, A. J., Bramer, L., Fansler, S. J., Hansen, J., Shukla, A. K., Jansson, J. K., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b09668 · Cited by 69
Restoration of Bacterial Microbiome Composition and Diversity Among Treatment Responders in a Phase 2 Trial of RBX2660: An Investigational Microbiome Restoration Therapeutic
Blount, K., Shannon, W. D., Deych, E., & Jones, C. R. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz095 · Cited by 68
Case report and literature review of auto-brewery syndrome: probably an underdiagnosed medical condition
Malik, F., Wickremesinghe, P. C., & Saverimuttu, J. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000325 · Cited by 66
Subinhibitory concentrations of metronidazole increase biofilm formation inClostridium difficilestrains
Vuotto, C., Moura, I. B., Barbanti, F., Donelli, G., & Spigaglia, P. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv114 · Cited by 63
Microbiome therapeutics go small molecule
Cully, M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00122-8 · Cited by 63
Adaptation of human gut microbiota to bariatric surgeries in morbidly obese patients: A systematic review
Ejtahed, H., Angoorani, P., Hasani‐Ranjbar, S., Siadat, S. D., Ghasemi, N., Larijani, B. A., & Soroush, A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.12.074 · Cited by 59
Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation
Huang, X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i22.5201 · Cited by 57
Design of the GutHeart—Targeting Gut Microbiota to Treat Heart Failure—Trial: A Phase II, Randomized Clinical Trial
Mayerhofer, C. C. K., Awoyemi, A., Moscavitch, S. D., Lappegård, K. T., Hov, J. R., Aukrust, P., Hovland, A., Lorenzo, A. D., Halvorsen, S., Seljeflot, I., et al. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12332 · Cited by 53
Mycins v MicrobesMissing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues by Martin J.Blaser (2014) HoltNew York, USA
Proctor, L. M. (2014) · The FASEB Journal · doi:10.1096/fj.14-0901ufm · Cited by 52
Gut Microbiota Modulation Attenuated the Hypolipidemic Effect of Simvastatin in High-Fat/Cholesterol-Diet Fed Mice
He, X., Zheng, N., Jiaojiao, H., Liu, C., Feng, J., Jia, W. P., & Li, H. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00984 · Cited by 50
Comparative analysis of the gut microbiota in distinct statin response patients in East China
Sun, B., Li, L., & Zhou, X. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8152-x · Cited by 40
The Inhibitory Effect of Ciprofloxacin on the β‐Glucuronidase‐mediated Deconjugation of the Irinotecan Metabolite SN‐38‐G
Kodawara, T., Higashi, T., Negoro, Y., Kamitani, Y., Igarashi, T., Watanabe, K., Tsukamoto, H., Yano, R., Masada, M., Iwasaki, H., et al. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12511 · Cited by 39
Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection
Nazareth, N., Magro, F., Castro, A. R., Cabral, J., Rodrigues, P., Silva, R., Appelberg, R., Rodrigues, S. G., Lopes, S., Macedo, G., et al. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.01.002 · Cited by 38
Human Microbiome as an Approach to Personalized Medicine.
Ejtahed, H., Hasani‐Ranjbar, S., & Larijani, B. A. (2017) · PubMed · Cited by 36
The gut microbiome and heart failure
Ahmad, A. F., Ward, N. C., & Dwivedi, G. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000598 · Cited by 35
Clostridioides difficileWhole-genome Sequencing Differentiates Relapse With the Same Strain From Reinfection With a New Strain
Cho, J. M., Cunningham, S. A., Pu, M., Lennon, R. J., Higano, J. D., Jeraldo, P., Sampathkumar, P., Shannon, S. K., Kashyap, P., & Patel, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa159 · Cited by 33
Self-citation
Drug-microbiota interactions and treatment response: Relevance to rheumatoid arthritis
Sayers, E., MacGregor, A. J., & Carding, S. R. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.4.642 · Cited by 33
The influence of the intestinal microflora to the efficacy of Rosuvastatin
Wang, L., Wang, Y., Wang, H., Zhou, X., Wei, X., Xie, Z., Zhang, Z., Wang, K., & Mu, J. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0801-x · Cited by 30
The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): A masked and controlled study
Ince, A., Yazıcı, Y., Hamuryudan, V., & Yazıcı, H. (1996) · Clinical Rheumatology · doi:10.1007/bf02229648 · Cited by 27
Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues
Shane, A. L. (2014) · Emerging infectious diseases · doi:10.3201/eid2011.141052 · Cited by 26
Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Tariq, R., Saha, S., Solanky, D., Pardi, D. S., & Khanna, S. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001398 · Cited by 26
Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib
Yamamoto, K., Kuzuya, T., Honda, T., Ito, T., Ishizu, Y., Nakamura, M., Miyahara, R., Kawashima, H., Ishigami, M., & Fujishiro, M. (2020) · Anticancer Research · doi:10.21873/anticanres.13996 · Cited by 25
Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin
Wu, N. C., Xie, J., Zheng, T., Nycholat, C. M., Grande, G., Paulson, J. C., Lerner, R. A., & Wilson, I. A. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.001 · Cited by 24
Potential therapeutic applications of the gut microbiome in obesity: from brain function to body detoxification
Choi, B. S.-Y., Daoust, L., Pilon, G., Marette, A., & Tremblay, A. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0618-3 · Cited by 20
Muramyl Dipeptides: Prospect for Cancer Treatments and Immunostimulation
Kotani, S., Azuma, I., Takada, H., TSUJIMOTO, M., & Yamamura, Y. (1983) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-1410-4_12 · Cited by 17
Comparative and quantitative assessment on statin efficacy and safety: insights into inter-statin and inter-individual variability via dose- and exposure-response relationships
Iwaki, Y., Lee, W., & Sugiyama, Y. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1681399 · Cited by 14
The Plot Thickens: Diet Microbe Interactions May Modulate Thrombosis Risk
Campo, A. M.-D., Romano, K. A., Rey, F. E., & Balskus, E. P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.017 · Cited by 10
Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review.
Mohammadi, Z., Poustchi, H., Motamed-Gorji, N., Eghtesad, S., Hekmatdoost, A., Saniee, P., & Merat, S. (2020) · PubMed · Cited by 10
Reversibility of abnormal auditory findings in cerebral hemisphere lesions
Gilroy, J., & Lynn, G. E. (1974) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(74)90065-3 · Cited by 6
[Evaluation of a semiautomatic system (ABAC-ABACTOR III) for the identification of Enterobacteriaceae].
Nani, E., Amato, G., Lavitola, A., & Morgantetti, F. (1985) · PubMed · Cited by 4

Flagged first, then by citations

1 of the 270 references couldn’t be matched to a known paper.

Sorted by citations

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Zhang, F., Lau, R. I., Liu, Q., Su, Q., Chan, F. K. L., & Ng, S. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00698-4 · Cited by 282
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations
Ni, Y., Qian, L., Siliceo, S. L., Long, X., Nychas, E., Liu, Y., Ismaiah, M. J., Leung, H., Zhang, L., Gao, Q., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.08.002 · Cited by 237
Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease
Jia, B., Zou, Y., Han, X., Bae, J., & Jeon, C. O. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.08.003 · Cited by 220
The future of engineered immune cell therapies
Irvine, D. J., Maus, M. V., Mooney, D. J., & Wong, W. W. (2022) · Science · doi:10.1126/science.abq6990 · Cited by 215
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Li, Z., Xiong, W., Zhu, L. W., Wang, J., Zeng, Z., Kołat, D., Li, X., Zhou, D., Xu, X., & Zhao, L.-Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01541-w · Cited by 197

See all 218

Authors: Schupack, D. A., Mars, R. A. T., Voelker, D. H., Abeykoon, J. P., & Kashyap, P. C.
Affiliations: Mayo Clinic (US)
Corresponding author: Kashyap, Purna C.
ORCID: Schupack, Daniel A.
Mars, Ruben A. T.
Voelker, Dayne H.
Abeykoon, Jithma P.
Kashyap, Purna C.
Venue: Nature Reviews Gastroenterology & Hepatology
Publisher: Springer Science and Business Media LLC
Published: 2021-08-27
Volume: 19
Issue: 1
Pages: 7-25
ISSN: 1759-5045 (ISSN-L)
1759-5053
DOI: 10.1038/s41575-021-00499-1
PMC: PMC8712374
OpenAlex: W3195493570
Cited by: 217
References: 270
Citations by year: 2026: 50 · 2025: 60 · 2024: 47 · 2023: 37 · 2022: 20 · 2021: 3
FWCI: 2.83
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Gastroenterology & Hepatology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (R01DK114007)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords: gut microbiota, personalized treatment, precision medicine, microbiota-based therapy, treatment response variability, infectious diseases, cancer, metabolic disorders, cardiovascular disease, autoimmune disease, pathogenesis, treatment-related adverse events
MeSH terms: Gastrointestinal Microbiome, Gastrointestinal Diseases, Humans, Liver Diseases, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The promise of the gut microbiome as part of individualized treatment strategies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks